Business Standard

Tuesday, December 24, 2024 | 04:19 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Coronil is no kadha: Patanjali's Covid-19 drug must go through scrutiny

Baba Ramdev's creations to fight Covid must go through the rigours of scientific verification and clinical trials before being sold in the market

patanjali, coronavirus, ramdev
Premium

Ramdev with Acharya Balkrishna (right) at the launch of Coronil and Swasari in Haridwar on Tuesday. PHOTO: PTI

Nivedita Mookerji
Even as controversy continues to rage around hydroxychloroquine (HCQ), the spotlight is on a new indigenous Covid-19 cure, Coronil. Unlike in the case of anti-malarial drug HCQ being used to prevent Covid, global majors such as the World Health Organisation (WHO) and Lancet have not reacted to Baba Ramdev’s creations, Divya Coronil and Swasari Vati, so far. Other authorities monitoring the medical side of the pandemic -- such as the Indian Council of Medical Research (ICMR) and the multiple high-powered committees including a taskforce headed by Niti Aayog member VK Paul -- too have not placed their observation in the
Disclaimer: These are personal views of the writer. They do not necessarily reflect the opinion of www.business-standard.com or the Business Standard newspaper

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in